NCT06330142 Hippotherapy Teenager-pediatric Radiotherapy
| NCT ID | NCT06330142 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Paul Strauss |
| Condition | Radiotherapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 22 participants |
| Start Date | 2024-06-19 |
| Primary Completion | 2027-06-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22 participants in total. It began in 2024-06-19 with a primary completion date of 2027-06-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study proposes a horse-assisted therapy (HAT) approach to accompany children and young adults undergoing irradiation in the ICANS Radiotherapy Department. The aim of this new approach is to improve quality of life and reduce anxiety in children and adolescents treated with radiotherapy. The impact of equine-assisted therapy on quality of life and anxiety disorders will be described prospectively between the start and end of irradiation in children and parents who agree to inclusion.
Eligibility Criteria
Inclusion Criteria: * Children aged 8 to \<18 years. * With an indication for radiotherapy for cancer (of any type) * Patients hospitalized and/or managed on an ambulatory basis * WHO ≤ 2 * Child and parents (or accompanying adults) who speak and understand French * Free, express and informed consent of the adult patient OR of those exercising parental authority for minor patients * Child with social security coverage Exclusion Criteria: * Children afraid of horses and stables * Contraindication to the practice of equine-assisted therapy (allergy to horses or dust, children with asthma attacks triggered by dust/animal hair ...) * Patient on stretcher * Children or parents (or carers) with significant cognitive impairment, making self-assessment or hetero-assessment impossible even with assistance * Unavailability or lack of interest in participating in equine-assisted therapy sessions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06330142 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 17 Years, studying Radiotherapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06330142 currently recruiting?
Yes, NCT06330142 is actively recruiting participants. Contact the research team at v.sartori@icans.eu for enrollment information.
Where is the NCT06330142 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT06330142 clinical trial?
NCT06330142 is sponsored by Centre Paul Strauss. The trial plans to enroll 22 participants.